Keryx Biopharmaceuticals (KERX): Zerenex- The New Spark For Keryx? - Seeking Alpha
Keryx (KERX) recently declared successful results from its phase II study of renal disease drug "Zerenex" in non-dialysis dependent chronic kidney disease, or NDD-CKD patients, who are suffering with elevated serum and phosphorus and iron-deficiency anemi...